You cannot know the power of an investment unless you see the returns. Many think of dividend stocks as a way of generating ...

This out-of-favor drug maker is taking the steps needed to ensure it not only survives but thrives over the long term.

Pfizer's Q3 earnings fell, but the company still raised its full-year earnings guidance. Major cost reductions remain on ...

Better still, if interest rates drop, as they're generally expected to over the coming year, the interest income you'll get ...

Boomers today are between 60 and 79 years old. You may be just a few years away from retirement, or it has been over a decade ...

Pfizer offers a 7% dividend yield, lower COVID sales, oncology and cardiometabolic focus, and growth from Metsera and ...

Pfizer offers an annual dividend yield of 6.98%, or $1.72 a year. Here's how investors can pocket a regular $500 monthly.

A second magnificent ultra-high-yield dividend stock that's begging to be bought in November is pharmaceutical titan Pfizer ...

We recently published a list of 13 Best Healthcare Dividend Stocks to Invest in. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best healthcare ...

We recently published a list of Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other top dividend contenders. Dividend ...

Pfizer Inc (Symbol: PFE) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a whopping $19.49B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a ...

Pfizer’s Q3 2025 earnings fell despite beating estimates. Weak growth and a stagnant outlook keep PFE stock a Hold.